Exhibit 99.2
Interim
Statement
| Balance Sheet | |
| Panoptes Pharma Ges.m.b.H. | |
| Assets | 30.09.2020 | 31.12.2019 | ||||||
| EUR | TEUR | |||||||
| A. Fixed Assets | ||||||||
| I. Intangible assets | ||||||||
| 1. Software | 0,00 | 0 | ||||||
| II. Property, plants and equipment | ||||||||
| 1. Office furniture and equipment | 1.673,64 | 0 | ||||||
| 1.673,64 | 0 | |||||||
| B. Current Assets | ||||||||
| I. Accounts receivable and other assets | ||||||||
| 1. Accounts receivable trade | 396,03 | 4 | ||||||
| of which with a residual term of more than one year | 0,00 | 0 | ||||||
| 2. Other receivables and assets | 58.440,13 | 157 | ||||||
| of which with a residual term of more than one year | 5.400,00 | 0 | ||||||
| 58.836,16 | 162 | |||||||
| II. Cash at banks | 642.620,36 | 571 | ||||||
| 701.456,52 | 732 | |||||||
| C. Deferred items | 1.548,12 | 0 | ||||||
| Total assets | 704.678,28 | 733 | ||||||
| Liabilities | 30.09.2020 | 31.12.2019 | ||||||
| EUR | TEUR | |||||||
| A. Negative Equity | ||||||||
| I. Called-up nominal capital | 52.186,07 | 52 | ||||||
| subscribed share capital | 52.186,07 | 52 | ||||||
| nominal capital paid up | 52.186,07 | 52 | ||||||
| II. Net loss | -3.793.557,72 | -3.256 | ||||||
| Of which loss carried forward | -3.255.628,38 | -4.912 | ||||||
| -3.741.371,65 | -3.203 | |||||||
| B. Reserves | ||||||||
| 1. Other reserves | 1.925.698,03 | 1.543 | ||||||
| C. Contributions from silent partners | 1.190.000,00 | 1.190 | ||||||
| D. Liabilities | ||||||||
| 1. Trade accounts payabale | 219.436,01 | 92 | ||||||
| of which with a residual term of up to one year | 219.436,01 | 92 | ||||||
| of which with a residual term of more than one year | 0,00 | 0 | ||||||
| 2. other liabilities | 1.110.915,89 | 1.111 | ||||||
| of which from taxes | 8.091,25 | 3 | ||||||
| of which from social security | 7.205,98 | 7 | ||||||
| of which with a residual term of up to one year | 1.110.915,89 | 1.111 | ||||||
| 1.330.351,90 | 1.203 | |||||||
| of which with a residual term of up to one year | 1.330.351,90 | 1.203 | ||||||
| of which with a residual term of more than one year | 0,00 | 0 | ||||||
| Total liabilities | 704.678,28 | 733 | ||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | Seite 2 |
| Income Statement | |
| Panoptes Pharma Ges.m.b.H. | vom 1. January 2020 to 30. Sept. 2020 |
| 2020 | 2019 | ||||||||
| EUR | TEUR | ||||||||
| 1. | Other operating income | 738.224,19 | 323 | ||||||
| 2. | Costs of materials and other purchased services | ||||||||
| a) Costs of materials | 5.117,00 | 5 | |||||||
| b) Costs of purchased services | 355.840,79 | 285 | |||||||
| 360.957,79 | 290 | ||||||||
| 3. | Personnel expenses | ||||||||
| a) Wages and salaries | 276.135,89 | 467 | |||||||
| of which salaries of management | 183.130,22 | 339 | |||||||
| b) Social security expenses | 59.604,79 | 83 | |||||||
| 335.740,68 | 550 | ||||||||
| 4. | Depreciation and amortization | ||||||||
| a) on intangible and tangible fixed assets | |||||||||
| 1.263,64 | 1 | ||||||||
| 5. | other operating expenses | 508.311,16 | 404 | ||||||
| 6. | Subtotal of items 1 through 5 (operating result) | -468.049,08 | -921 | ||||||
| 7. | other interest and similar income | 34,31 | 24 | ||||||
| 8. | interest and similar expenses | 68.914,57 | 8 | ||||||
| 9. | Subtotal of items 7 through 8 (financial result) | -68.880,26 | 16 | ||||||
| 10. | Earnings before taxes (sum of items 6 and 9) | -536.929,34 | -905 | ||||||
| 11. | Taxes on income | 1.000,00 | 1 | ||||||
| 12. | Profit after tax | -537.929,34 | -906 | ||||||
| 13. | Net loss for the year | -537.929,34 | -906 | ||||||
| 14. | Release of capital reserves | 0,00 | 2.562 | ||||||
| 15. | Loss carried forward from the previous year | -3.255.628,38 | -4.912 | ||||||
| 16. | Accumulated loss | -3.793.557,72 | -3.256 | ||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | Page 3 |
| Panoptes Pharma Ges.m.b.H. | List of fAssets |
| Acquisition/production costs | Accumulated depreciation | Book values | ||||||||||||||||||||||||||||||||||||||||||||||
| Status | Additions | Disposals | Reclassifications | Status | Status | Depreciation | Allocations | Disposals | Status | Status | Stand | |||||||||||||||||||||||||||||||||||||
| 01.01.2020 | 30.09.2020 | 01.01.2020 | 30.09.2020 | 01.01.2020 | 30.09.2020 | |||||||||||||||||||||||||||||||||||||||||||
| EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | |||||||||||||||||||||||||||||||||||||
| A. Fixed assets | ||||||||||||||||||||||||||||||||||||||||||||||||
| I. Intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||
| 1. Software | 8.652,00 | 0,00 | 0,00 | 0,00 | 8.652,00 | 8.652,00 | 0,00 | 0,00 | 0,00 | 8.652,00 | 0,00 | 0,00 | ||||||||||||||||||||||||||||||||||||
| II. Property, plant and equipment | ||||||||||||||||||||||||||||||||||||||||||||||||
| 1. Office furniture and equipment | 7.272,41 | 2.284,15 | 0,00 | 0,00 | 9.556,56 | 6.820,62 | 1.062,30 | 0,00 | 0,00 | 7.882,92 | 451,79 | 1.673,64 | ||||||||||||||||||||||||||||||||||||
| 15.924,41 | 2.284,15 | 0,00 | 0,00 | 18.208,56 | 15.472,62 | 1.062,30 | 0,00 | 0,00 | 16.534,92 | 451,79 | 1.673,64 | |||||||||||||||||||||||||||||||||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | Page 4 |
Notes on the Balance
Sheet and Income
Statement
| Notes on the balance sheet and income | |
| Panoptes Pharma Ges.m.b.H. | statement |
1 Notes on the balance sheet and income statement
| Assets | ||||||||
| A. Fixed Assets | ||||||||
| I. Intangible Assets | ||||||||
| Changes in book value: | ||||||||
| EUR | ||||||||
| Status 01.01.2020 | 0,00 | |||||||
| Status 30.09.2020 | 0,00 |
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Website | 0,00 | 0,00 |
| II. Property, Plant and Equipment | ||||||||
| Changes in book value: | ||||||||
| EUR | ||||||||
| Status 01.01.2020 | 451,79 | |||||||
| Addition | 2 284,15 | |||||||
| Depreciation and amortization | -1 062,30 | |||||||
| Status 30.09.2020 | 1 673,64 |
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Office equipment, computer systems | 1 673,64 | 451,79 |
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 5 |
| Notes on the balance sheet and income | |
| Panoptes Pharma Ges.m.b.H. | statement |
| B. Current assets | ||||||||
| 1. Accounts receivable trade | ||||||||
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Creditors with debit accounts | 396,03 | 4 300,00 |
| I. Receivables and other assets | ||||||||
| 2. Other receivables and assets |
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Receivable research premium | 51 230,06 | 146 003,91 | ||||||
| Deposits | 5 400,00 | 5 400,00 | ||||||
| Settlement VAT | 1 810,07 | 3 813,43 | ||||||
| Input tax Germany | 0,00 | 1 117,20 | ||||||
| Settlement account Sperl | 0,00 | 675,00 | ||||||
| Other receivables | 0,00 | 146,25 | ||||||
| Settlement account Obermayr | 0,00 | 58,75 | ||||||
| 58 440,13 | 157 214,54 |
| II. Cash at banks | ||||||||
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Erste Bank 823-175-016 | 542 319,96 | 470 239,34 | ||||||
| Deposit account Erste Bank | 50 300,40 | 100 298,78 | ||||||
| Deposit account Erste Bank 823-175-016/02 | 50 000,00 | 0,00 | ||||||
| 642 620,36 | 570 538,12 |
| C. Accruals and deferrals | ||||||||
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| accrued income | 1 548,12 | 318,32 |
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 6 |
| Notes on the balance sheet and income | |
| Panoptes Pharma Ges.m.b.H. | statement |
| Liabilities | ||||||||
| A. Negative equity | ||||||||
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Called-up share capital | 52 186,07 | 52 186,07 | ||||||
| Subscribed share capital | 52 186,07 | 52 186,07 | ||||||
| Paid-in share capital | 52 186,07 | 52 186,07 | ||||||
| Net loss | -3 793 557,72 | -3 255 628,38 | ||||||
| Of which loss carried forward | -3 255 628,38 | -4 911 609,00 | ||||||
| -3 741 371,65 | -3 203 442,31 | |||||||
| Development of net loss: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Profit/loss for the year | -537 929,34 | 1 655 980,62 | ||||||
| Loss carried forward from previous years | -3 255 628,38 | -4 911 609,00 | ||||||
| -3 793 557,72 | -3 255 628,38 |
| B. Reserves | ||||||||||||||||||||
| Composition and development: | ||||||||||||||||||||
| Status | Status | |||||||||||||||||||
| 01.01.2020 | Use | Release | Allocation | 30.09.2020 | ||||||||||||||||
| EUR | EUR | EUR | EUR | EUR | ||||||||||||||||
| Other reserves | 1 543 383,41 | 34 108,82 | 103,60 | 416 527,04 | 1 925 698,03 |
| Composition and development of other reserves: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Reserves for repayment aws | 1 000 000,00 | 956 317,00 | ||||||
| Reserves for premiums | 500 887,72 | 479 808,15 | ||||||
| Reserves for repayment FFG | 276 108,12 | 0,00 | ||||||
| Reserves for third-party services | 63 045,84 | 60 998,84 | ||||||
| Vacation reserves | 27 941,84 | 11 259,42 | ||||||
| Other reserves | 23 000,00 | 15 000,00 | ||||||
| Reserves for advisory board fees | 20 000,00 | 20 000,00 | ||||||
| Reserves for special payments | 14 714,51 | 0,00 | ||||||
| 1 925 698,03 | 1 543 383,41 |
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 7 |
| Notes on the balance sheet and income | |
| Panoptes Pharma Ges.m.b.H. | statement |
| C. Capital contributions silent partners | ||||||||
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Capital contributions atypical silent partner ACP 2016 | 400 000,00 | 400 000,00 | ||||||
| Capital contributions atypical silent partner ACP 2015 | 275 000,00 | 275 000,00 | ||||||
| Capital contributions atypical silent partner ACP 2016.eins | 265 000,00 | 265 000,00 | ||||||
| Capital contributions atypical silent partner ACP 2017 | 250 000,00 | 250 000,00 | ||||||
| 1 190 000,00 | 1 190 000,00 |
| D. Liabilities | ||||||||
| 1. Accounts payable trade | ||||||||
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Deferral accounts payable trade | 183 481,23 | 36 466,10 | ||||||
| Trade payables EU | 31 574,76 | 34 317,31 | ||||||
| Trade payables third countries | 2 472,74 | 0,00 | ||||||
| Trade payables domestic | 1 907,28 | 21 278,64 | ||||||
| 219 436,01 | 92 062,05 | |||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 8 |
| Notes on the balance sheet and income | ||
| Panoptes Pharma Ges.m.b.H. | statement | |
| 2. Other liabilities | ||||||||
| Composition: | ||||||||
| 30.09.2020 | 31.12.2019 | |||||||
| EUR | EUR | |||||||
| Loan FFG | 1 095 044,00 | 1 095 044,00 | ||||||
| Balance payroll taxes | 8 091,75 | 8 249,41 | ||||||
| Social security providers | 7 205,98 | 7 118,02 | ||||||
| Balance credit card | 324,66 | 5 854,40 | ||||||
| Remaining other liabilities | 250,00 | 0,00 | ||||||
| Balance tax office | -0,50 | -5 446,21 | ||||||
| 1 110 915,89 | 1 110 819,62 | |||||||
| of which from taxes | 30.09.2020 | 31.12.2019 | ||||||
| EUR | EUR | |||||||
| Balance charges linked to salaries and wages | 8 091,75 | 8 249,41 | ||||||
| Balance tax offices | -0,50 | -5 446,21 | ||||||
| 8 091,25 | 2 803,20 | |||||||
| Of which relating to social security | 30.09.2020 | 31.12.2019 | ||||||
| EUR | EUR | |||||||
| Social security providers | 7 205,98 | 7 118,02 |
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 9 |
| Notes on the balance sheet and income | ||
| Panoptes Pharma Ges.m.b.H. | statement | |
Income Statement
| 1. Other operating income | ||||||||
| Income from the release of reserves | ||||||||
| Composition: | ||||||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Release other reserves | 103,60 | 77 003,23 | ||||||
| Remaining | ||||||||
| Composition: | ||||||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Grant FFG - Covid 19 | 586 150,00 | 0,00 | ||||||
| Grant Wirtschaftsagentur Research 18-21 | 100 000,00 | 100 000,00 | ||||||
| Other operational income (non-taxable) | 51 230,06 | 146 003,91 | ||||||
| Exchange gains foreign currency transactions | 712,96 | 0,00 | ||||||
| Other operational income | 27,57 | 83,52 | ||||||
| 738 120,59 | 246 087,43 | |||||||
| 2. Costs of material and other purchased manufacturing services | ||||||||
| a. Costs of material | ||||||||
| Composition: | ||||||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Laboratory chemicals | 5 117,00 | 4 730,00 |
| b. Costs of purchased services | ||||||||
| Composition: | ||||||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Third-party services from abroad, reverse charge | 354 960,79 | 269 648,42 | ||||||
| Third-party services | 880,00 | 15 522,99 | ||||||
| Exchange losses foreign currency transactions | 0,00 | 18,26 | ||||||
| Cash discounts 20% other services EU | 0,00 | -303,26 | ||||||
| 355 840,79 | 284 886,41 | |||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 10 |
| Notes on the balance sheet and income | ||
| Panoptes Pharma Ges.m.b.H. | statement | |
| 3. Personnel costs | ||||||||
| a. Wages and salaries | ||||||||
| Composition: | ||||||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Salaries (management) | 155 571,39 | 198 000,00 | ||||||
| Salaries | 55 206,00 | 74 666,40 | ||||||
| Special payments (management) | 27 558,83 | 36 500,00 | ||||||
| Change in vacation provision (white-collar employees) | 16 682,42 | 4 599,42 | ||||||
| Special payments (white-collar employees) | 11 124,54 | 28 764,83 | ||||||
| Bonuses and commission (white-collar employees) | 6 300,90 | 8 401,20 | ||||||
| Wages | 3 150,00 | 3 420,00 | ||||||
| Special payments (blue-collar workers) | 541,81 | 570,00 | ||||||
| Changes in reserves for bonuses and premiums (management) | 0,00 | 104 960,24 | ||||||
| Changes in reserves for bonuses and premiums | 0,00 | 7 230,00 | ||||||
| 276 135,89 | 467 112,09 | |||||||
| Of which salaries of management | ||||||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Salaries (management) | 155 571,39 | 198 000,00 | ||||||
| Special payments (management) | 27 558,83 | 36 500,00 | ||||||
| Changes in reserves for bonuses and premiums (management) | 0,00 | 104 960,24 | ||||||
| 183 130,22 | 339 460,24 | |||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 11 |
| Notes on the balance sheet and income | ||
| Panoptes Pharma Ges.m.b.H. | statement | |
| b. Social expenses | |||
| Composition: |
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Statutory social expenses (white-collar employees) | 38 411,66 | 52 099,46 | ||||||
| Employer contribution (white-collar employees) | 9 408,33 | 13 506,90 | ||||||
| Municipal tax (white-collar employees) | 7 237,14 | 10 389,95 | ||||||
| Company pension fund (white-collar employees) | 3 691,05 | 5 296,13 | ||||||
| Vienna employer levy (subway, white-collar employees) | 312,00 | 416,00 | ||||||
| Voluntary social expenses | 207,52 | 879,21 | ||||||
| Employer contribution (blue-collar workers) | 136,50 | 155,66 | ||||||
| Municipal tax (blue-collar workers) | 105,00 | 119,70 | ||||||
| Company pension fund (blue-collar workers) | 53,59 | 61,04 | ||||||
| Statutory social expenses (blue-collar workers) | 42,00 | 47,88 | ||||||
| 59 604,79 | 82 971,93 | |||||||
| 4. Depreciation and amortization | |||
| Composition: |
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Depreciation of property, plant and equipment | 1 062,30 | 368,62 | ||||||
| low-value tangible fixed assets | 201,34 | 145,00 | ||||||
| Depreciation of intangible fixed assets | 0,00 | 0,28 | ||||||
| 1 263,64 | 513,90 | |||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 12 |
| Notes on the balance sheet and income | ||
| Panoptes Pharma Ges.m.b.H. | statement | |
| 5. | Other operational expenses | |||||
| Composition: | ||||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Repayment FFG Grant | 276 108,12 | 0,00 | ||||||
| Legal, consulting and auditing fees | 171 076,20 | 173 363,50 | ||||||
| Expenses for rent, licenses and patents | 26 676,48 | 55 755,67 | ||||||
| Expenditure for insurance | 8 886,71 | 4 895,77 | ||||||
| Expenditure communication | 6 901,96 | 10 964,26 | ||||||
| Expenditure search for investors | 6 794,69 | 87 457,25 | ||||||
| Travel expenses | 3 654,89 | 43 193,88 | ||||||
| Expenditure for advertising, operational donations and presentation | 2 377,53 | 8 363,28 | ||||||
| Transportation expenses | 1 632,54 | 6 862,47 | ||||||
| Expenditure for maintenance, operating costs | 1 544,04 | 3 233,25 | ||||||
| IT Expenses | 994,20 | 687,50 | ||||||
| Charges on monetary transactions | 971,70 | 1 289,64 | ||||||
| Expenses for office supplies | 420,60 | 1 923,71 | ||||||
| Membership dues | 137,50 | 0,00 | ||||||
| Software maintenance | 133,91 | 0,00 | ||||||
| Training and development | 0,00 | 3 816,76 | ||||||
| Fees and charges | 0,00 | 2 240,00 | ||||||
| Various operating expenses | 0,09 | 27,37 | ||||||
| 508 311,16 | 404 074,31 | |||||||
| 6. | Subtotal of items 1 through 5 (Operating result) | 2020 | EUR | -468 049,08 | ||||||||||
| 2019 | EUR | -921 197,98 |
| 7. | Other interest and similar income | |||
| Composition: | ||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Interest income from bank balances | 34,31 | 70,40 | ||||||
| Interest income from discounting of long-term provisions | 0,00 | 24 346,27 | ||||||
| 34,31 | 24 416,67 | |||||||
| Haimerl Hörler Wirtschaftsprüfer Steuerberater GmbH | 13 |
| Notes on the balance sheet and income | ||
| Panoptes Pharma Ges.m.b.H. | statement | |
| 8. | Interest and similar expenses |
Composition:
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Interest expense non-current provisions | 64 762,57 | 0,00 | ||||||
| Interest on loans | 4 152,00 | 8 327,00 | ||||||
| 68 914,57 | 8 327,00 | |||||||
| 9. | Subtotal from items 7 through 8 (Financial result) | 2020 | EUR | -68 880,26 | |||||||||
| 2019 | EUR | 16 089,67 | |||||||||||
| 10. | Earnings before taxes (Total from items 6 and 9) | 2020 | EUR | -536 929,34 | |||||||||
| 2019 | EUR | -905 108,31 | |||||||||||
| 11. Taxes on income | ||||
| Composition: | ||||
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Corporate income tax | 1 000,00 | 875,00 | ||||||
| 12. | Earnings after taxes | 2020 | EUR | -537 929,34 | |||||||||
| 2019 | EUR | -905 983,31 | |||||||||||
| 13. | Net loss for the year | 2020 | EUR | -537 929,34 | |||||||||
| 2019 | EUR | -905 983,31 | |||||||||||
| 14. Release of capital reserves | |||
| Composition: |
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Release of other (unrestricted) reserves | 0,00 | 2 561 963,93 | ||||||
| 15. | Loss carried forward from previous year |
Composition:
| 2020 | 2019 | |||||||
| EUR | EUR | |||||||
| Loss carried forward from the previous year | -3 255 628,38 | -4 911 609,00 | ||||||
| 16. | Accumulated loss | 2020 | EUR | -3 793 557,72 | |||||||||
| 2019 | EUR | -3 255 628,38 | |||||||||||